Chronic obstructive pulmonary disease prognostic score: A new index
The evaluation of chronic obstructive pulmonary disease (COPD) has been shifting from spirometry to focus on the patients' overall health. Despite the existence of many COPD prognostic scales, there remains a large gap for improvement, in particular a scale that incorporates the current focus o...
Saved in:
Published in: | Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia Vol. 160; no. 2; pp. 211 - 218 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Czech Republic
Palacký University Olomouc, Faculty of Medicine and Dentistry
01-06-2016
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | The evaluation of chronic obstructive pulmonary disease (COPD) has been shifting from spirometry to focus on the patients' overall health. Despite the existence of many COPD prognostic scales, there remains a large gap for improvement, in particular a scale that incorporates the current focus on overall health.
We proposed a new prognostic scale (the COPD Prognostic Score) through discussion among the authors based on published studies. Validation was retrospective, using data from the National Emphysema Treatment Trial.
The scores ranged from 0-16, where 16 indicated the poorest prognosis. We assigned 4 points each for forced expiratory volume in one second (%predicted), the modified Medical Research Council dyspnea scale, and age; 2 points for the hemoglobin level; and one point each for decreased activity and respiratory emergency admission in the last two years. The validation cohort included 607 patients and consisted of 388 men (73.9%) and 219 women (36.1%), mean age 67 ± 6 years and an average forced expiratory volume in one second (% predicted) of 27 ± 7%. A one-point increase in the score was associated with increased all-cause death, with a hazard ratio of 1.28 (95%CI: 1.21-1.36. P < 0.001). The areas under the receiver operating characteristic curves for two-year and five-year all-cause death for the new scale were 0.72 and 0.66, respectively. These values were higher than those given by the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index and age, dyspnea, airway obstruction (ADO) index.
The preliminary validation for a new COPD prognostic scale: the COPD Prognostic Score was developed with promising results thus far. Above mentioned 16-point score accurately predicted 2-year and 5-year all-cause mortality among subjects who suffered from severe and very severe COPD. |
---|---|
AbstractList | Background: The evaluation of chronic obstructive pulmonary disease (COPD) has been shifting from spirometry to focus on the patients' overall health. Despite the existence of many COPD prognostic scales, there remains a large gap for improvement, in particular a scale that incorporates the current focus on overall health. Methods: We proposed a new prognostic scale (the COPD Prognostic Score) through discussion among the authors based on published studies. Validation was retrospective, using data from the National Emphysema Treatment Trial. Results: The scores ranged from 0-16, where 16 indicated the poorest prognosis. We assigned 4 points each for forced expiratory volume in one second (%predicted), the modified Medical Research Council dyspnea scale, and age; 2 points for the hemoglobin level; and one point each for decreased activity and respiratory emergency admission in the last two years. The validation cohort included 607 patients and consisted of 388 men (73.9%) and 219 women (36.1%), mean age 67 ± 6 years and an average forced expiratory volume in one second (% predicted) of 27 ± 7%. A one-point increase in the score was associated with increased all-cause death, with a hazard ratio of 1.28 (95%CI: 1.21-1.36. P < 0.001). The areas under the receiver operating characteristic curves for two-year and five-year all-cause death for the new scale were 0.72 and 0.66, respectively. These values were higher than those given by the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index and age, dyspnea, airway obstruction (ADO) index. Conclusion: The preliminary validation for a new COPD prognostic scale: the COPD Prognostic Score was developed with promising results thus far. Above mentioned 16-point score accurately predicted 2-year and 5-year all-cause mortality among subjects who suffered from severe and very severe COPD. BACKGROUNDThe evaluation of chronic obstructive pulmonary disease (COPD) has been shifting from spirometry to focus on the patients' overall health. Despite the existence of many COPD prognostic scales, there remains a large gap for improvement, in particular a scale that incorporates the current focus on overall health.METHODSWe proposed a new prognostic scale (the COPD Prognostic Score) through discussion among the authors based on published studies. Validation was retrospective, using data from the National Emphysema Treatment Trial.RESULTSThe scores ranged from 0-16, where 16 indicated the poorest prognosis. We assigned 4 points each for forced expiratory volume in one second (%predicted), the modified Medical Research Council dyspnea scale, and age; 2 points for the hemoglobin level; and one point each for decreased activity and respiratory emergency admission in the last two years. The validation cohort included 607 patients and consisted of 388 men (73.9%) and 219 women (36.1%), mean age 67 ± 6 years and an average forced expiratory volume in one second (% predicted) of 27 ± 7%. A one-point increase in the score was associated with increased all-cause death, with a hazard ratio of 1.28 (95%CI: 1.21-1.36. P < 0.001). The areas under the receiver operating characteristic curves for two-year and five-year all-cause death for the new scale were 0.72 and 0.66, respectively. These values were higher than those given by the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index and age, dyspnea, airway obstruction (ADO) index.CONCLUSIONThe preliminary validation for a new COPD prognostic scale: the COPD Prognostic Score was developed with promising results thus far. Above mentioned 16-point score accurately predicted 2-year and 5-year all-cause mortality among subjects who suffered from severe and very severe COPD. The evaluation of chronic obstructive pulmonary disease (COPD) has been shifting from spirometry to focus on the patients' overall health. Despite the existence of many COPD prognostic scales, there remains a large gap for improvement, in particular a scale that incorporates the current focus on overall health. We proposed a new prognostic scale (the COPD Prognostic Score) through discussion among the authors based on published studies. Validation was retrospective, using data from the National Emphysema Treatment Trial. The scores ranged from 0-16, where 16 indicated the poorest prognosis. We assigned 4 points each for forced expiratory volume in one second (%predicted), the modified Medical Research Council dyspnea scale, and age; 2 points for the hemoglobin level; and one point each for decreased activity and respiratory emergency admission in the last two years. The validation cohort included 607 patients and consisted of 388 men (73.9%) and 219 women (36.1%), mean age 67 ± 6 years and an average forced expiratory volume in one second (% predicted) of 27 ± 7%. A one-point increase in the score was associated with increased all-cause death, with a hazard ratio of 1.28 (95%CI: 1.21-1.36. P < 0.001). The areas under the receiver operating characteristic curves for two-year and five-year all-cause death for the new scale were 0.72 and 0.66, respectively. These values were higher than those given by the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index and age, dyspnea, airway obstruction (ADO) index. The preliminary validation for a new COPD prognostic scale: the COPD Prognostic Score was developed with promising results thus far. Above mentioned 16-point score accurately predicted 2-year and 5-year all-cause mortality among subjects who suffered from severe and very severe COPD. |
Author | Hejduk, Karel Koblizek, Vladimir Kaneko, Takeshi Novotna, Barbora Plutinsky, Marek Horita, Nobuyuki |
Author_xml | – sequence: 1 givenname: Nobuyuki surname: Horita fullname: Horita, Nobuyuki organization: Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan – sequence: 2 givenname: Vladimir surname: Koblizek fullname: Koblizek, Vladimir organization: Department of Pneumology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic – sequence: 3 givenname: Marek surname: Plutinsky fullname: Plutinsky, Marek organization: Department of Pneumology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic – sequence: 4 givenname: Barbora surname: Novotna fullname: Novotna, Barbora organization: Department of Pneumology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic – sequence: 5 givenname: Karel surname: Hejduk fullname: Hejduk, Karel organization: Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic – sequence: 6 givenname: Takeshi surname: Kaneko fullname: Kaneko, Takeshi organization: Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27364317$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kUlPwzAQhS1UxH7ijnJEQin2eEu5VRWbhMQFzpZjTyAojYudsPx7DC09zWj06c2beYdk0oceCTlldCol1Zf1agqUqSnldIccsIqKUktgk9wD42XFWLVPDlN6o1QBMLFH9kFzJTjTB2SxeI2hb10R6jTE0Q3tBxarsVuG3sbvwrcJbcqTGF76kIYMJhciXhXzosfPou09fh2T3cZ2CU829Yg831w_Le7Kh8fb-8X8oXR8BkM5A4fCaz_TAhkDp4FKWwnJNVjvUQjhVdN45RvtQVoQshIKHK0xX1czwY_I_VrXB_tmVrFdZosm2Nb8DUJ8MTZmix0ar7FGNRNWgReeskpaTSkH0SgL2U7WOl9r5cveR0yDWbbJYdfZHsOYTH5j3sgUkxm9WKMuhpQiNtvVjJrfBEy9Mr8JmJxAps82wmO9RL9l_1_OfwAhwYFj |
CitedBy_id | crossref_primary_10_17116_profmed20222511154 crossref_primary_10_1186_s12890_022_01911_5 crossref_primary_10_21518_2079_701X_2018_12_182_184 crossref_primary_10_1136_bmj_l5358 |
Cites_doi | 10.1183/09031936.00137106 10.1056/NEJMoa021322 10.1164/rccm.2112043 10.2147/COPD.S71828 10.1136/thx.2006.060145 10.1182/blood-2005-10-4308 10.1016/S0140-6736(09)62084-5 10.1093/qjmed/hcl110 10.1164/ajrccm/145.6.1321 10.1378/chest.121.5.1434 10.1183/09031936.06.00143704 10.1378/chest.116.6.1632 10.1378/chest.93.3.580 10.1164/rccm.200510-1677OC 10.3109/15412555.2013.836171 10.1164/arrd.1986.133.1.14 10.1016/S0022-5223(99)70191-1 10.1136/thx.2005.040527 10.1164/ajrccm.160.6.9902115 10.1186/1741-7015-8-28 10.1097/00000421-198212000-00014 10.1378/chest.128.3.1201 10.1164/rccm.200507-1057OC 10.1111/crj.2014.8.issue-2 10.1164/ajrccm.152.3.7663812 10.1016/S0140-6736(09)61301-5 10.1378/chest.113.3.619 10.1016/S0140-6736(09)62083-3 10.3109/15412555.2013.808615 10.1016/j.rmed.2011.09.005 10.4193/Rhino11.051 10.1093/aje/kwg207 10.1164/ajrccm.154.4.8887592 10.1183/09031936.00096108 10.1001/archinternmed.2007.37 10.1016/S0885-3924(02)00690-5 10.1183/09031936.00189010 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 DOA |
DOI | 10.5507/bp.2016.030 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Engineering |
EISSN | 1804-7521 |
EndPage | 218 |
ExternalDocumentID | oai_doaj_org_article_d7ebe694a62d4d0185a700324f6a2c39 10_5507_bp_2016_030 27364317 |
Genre | Validation Studies Journal Article |
GroupedDBID | -~X 2WC 36B 53G ADBBV ALMA_UNASSIGNED_HOLDINGS BAWUL C1A CGR CUY CVF DIK EBD ECM EIF EMB EMOBN EOJEC F5P GROUPED_DOAJ GX1 ML~ NPM OBODZ OK1 SV3 TR2 AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c392t-92ce4d7d974e112c7205a845372adde444d6ffd6df7d25a2458462c0be016b143 |
IEDL.DBID | DOA |
ISSN | 1213-8118 |
IngestDate | Tue Oct 22 15:12:42 EDT 2024 Fri Jun 28 16:29:00 EDT 2024 Fri Aug 23 03:22:55 EDT 2024 Thu May 23 23:23:59 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | dyspnea spirometry prognosis age hemoglobin COPD |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c392t-92ce4d7d974e112c7205a845372adde444d6ffd6df7d25a2458462c0be016b143 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doaj.org/article/d7ebe694a62d4d0185a700324f6a2c39 |
PMID | 27364317 |
PQID | 1801431615 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_d7ebe694a62d4d0185a700324f6a2c39 proquest_miscellaneous_1801431615 crossref_primary_10_5507_bp_2016_030 pubmed_primary_27364317 |
PublicationCentury | 2000 |
PublicationDate | 2016-Jun |
PublicationDateYYYYMMDD | 2016-06-01 |
PublicationDate_xml | – month: 06 year: 2016 text: 2016-Jun |
PublicationDecade | 2010 |
PublicationPlace | Czech Republic |
PublicationPlace_xml | – name: Czech Republic |
PublicationTitle | Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia |
PublicationTitleAlternate | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub |
PublicationYear | 2016 |
Publisher | Palacký University Olomouc, Faculty of Medicine and Dentistry |
Publisher_xml | – name: Palacký University Olomouc, Faculty of Medicine and Dentistry |
References | ref13 ref35 ref12 ref34 ref15 ref37 ref14 ref36 ref31 ref30 ref11 ref33 ref10 ref32 ref2 ref17 ref16 ref38 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 Global Strategy (ref0) 2014 |
References_xml | – ident: ref35 doi: 10.1183/09031936.00137106 – ident: ref3 doi: 10.1056/NEJMoa021322 – ident: ref23 doi: 10.1164/rccm.2112043 – ident: ref37 doi: 10.2147/COPD.S71828 – ident: ref24 doi: 10.1136/thx.2006.060145 – ident: ref36 doi: 10.1182/blood-2005-10-4308 – ident: ref13 doi: 10.1016/S0140-6736(09)62084-5 – volume-title: Global Initiative for Chronic Obstructive Lung Disease (GOLD year: 2014 ident: ref0 contributor: fullname: Global Strategy – ident: ref5 doi: 10.1093/qjmed/hcl110 – ident: ref21 doi: 10.1164/ajrccm/145.6.1321 – ident: ref15 doi: 10.1378/chest.121.5.1434 – ident: ref33 doi: 10.1183/09031936.06.00143704 – ident: ref16 doi: 10.1378/chest.116.6.1632 – ident: ref17 doi: 10.1378/chest.93.3.580 – ident: ref20 doi: 10.1164/rccm.200510-1677OC – ident: ref10 doi: 10.3109/15412555.2013.836171 – ident: ref2 doi: 10.1164/arrd.1986.133.1.14 – ident: ref11 doi: 10.1016/S0022-5223(99)70191-1 – ident: ref29 doi: 10.1136/thx.2005.040527 – ident: ref27 doi: 10.1164/ajrccm.160.6.9902115 – ident: ref6 doi: 10.1186/1741-7015-8-28 – ident: ref26 doi: 10.1097/00000421-198212000-00014 – ident: ref34 doi: 10.1378/chest.128.3.1201 – ident: ref32 doi: 10.1164/rccm.200507-1057OC – ident: ref22 doi: 10.1111/crj.2014.8.issue-2 – ident: ref30 doi: 10.1164/ajrccm.152.3.7663812 – ident: ref4 doi: 10.1016/S0140-6736(09)61301-5 – ident: ref18 doi: 10.1378/chest.113.3.619 – ident: ref14 doi: 10.1016/S0140-6736(09)62083-3 – ident: ref19 doi: 10.3109/15412555.2013.808615 – ident: ref9 doi: 10.1016/j.rmed.2011.09.005 – ident: ref38 doi: 10.4193/Rhino11.051 – ident: ref25 doi: 10.1093/aje/kwg207 – ident: ref28 doi: 10.1164/ajrccm.154.4.8887592 – ident: ref31 doi: 10.1183/09031936.00096108 – ident: ref7 doi: 10.1001/archinternmed.2007.37 – ident: ref12 doi: 10.1016/S0885-3924(02)00690-5 – ident: ref8 doi: 10.1183/09031936.00189010 |
SSID | ssj0062214 |
Score | 2.1274815 |
Snippet | The evaluation of chronic obstructive pulmonary disease (COPD) has been shifting from spirometry to focus on the patients' overall health. Despite the... BACKGROUNDThe evaluation of chronic obstructive pulmonary disease (COPD) has been shifting from spirometry to focus on the patients' overall health. Despite... Background: The evaluation of chronic obstructive pulmonary disease (COPD) has been shifting from spirometry to focus on the patients' overall health. Despite... |
SourceID | doaj proquest crossref pubmed |
SourceType | Open Website Aggregation Database Index Database |
StartPage | 211 |
SubjectTerms | age Aged copd dyspnea Dyspnea - mortality Dyspnea - physiopathology Female Forced Expiratory Volume - physiology hemoglobin Hemoglobins - metabolism Humans Kaplan-Meier Estimate Male Middle Aged Prognosis Pulmonary Disease, Chronic Obstructive - mortality Pulmonary Disease, Chronic Obstructive - physiopathology Retrospective Studies Severity of Illness Index spirometry Spirometry - methods Surveys and Questionnaires Walking - physiology |
Title | Chronic obstructive pulmonary disease prognostic score: A new index |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27364317 https://search.proquest.com/docview/1801431615 https://doaj.org/article/d7ebe694a62d4d0185a700324f6a2c39 |
Volume | 160 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrZ09T8MwEIYt6AQD4pvwJSN1NU0urp2wQWnViQWQ2CwntieUVpQi8e-5i9OqC2JhjaI4fs_yvZbPjxnrp77MLORBBKWkkEoGUfmiFLqooFDelhLo7PD0WT-9FY9jwuSsr_qimrCIB47CDZzGZlQprQInXYrpxWociSCDslDn8eheqlaLqTgHK4CW6k28MlGgh44n84jdNaiIUpmp27bweSMXtcj-331mm28m-2yvM4r8Pv7gAdvyzSHb3cAHHrFRR7bls6rDwH55Pl--48iyH9-823vhVILVzIjHzBcErbzj9xzNNG9BicfsdTJ-GU1FdymCwM7Cpyih9tJph-sAj16p1pAObSGHuQaaqqSUToXglAvawdAC7YMqqNPKY6crdEcnrNfMGn_GOCoLufK6UHWQdaYtoVgwp4UqSPx0lrD-Sh4zj-wLg2sGUtFUc0MqGlQxYQ8k3foVAla3DzCMpguj-SuMCbtZCW9wgNOuhW38bLkwGfFtcjKmCTuNEVk3hd5LkQM6_49fuGA71KVYB3bJehg4f8W2F2553Q6uH2DRz50 |
link.rule.ids | 315,782,786,866,2106,27933,27934 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chronic+obstructive+pulmonary+disease+prognostic+score%3A+A+new+index&rft.jtitle=Biomedical+papers+of+the+Medical+Faculty+of+the+University+Palack%C3%BD%2C+Olomouc%2C+Czechoslovakia&rft.au=Horita%2C+Nobuyuki&rft.au=Koblizek%2C+Vladimir&rft.au=Plutinsky%2C+Marek&rft.au=Novotna%2C+Barbora&rft.date=2016-06-01&rft.issn=1213-8118&rft.volume=160&rft.issue=2&rft.spage=211&rft.epage=218&rft_id=info:doi/10.5507%2Fbp.2016.030&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1213-8118&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1213-8118&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1213-8118&client=summon |